KRTL BioTech

Alibaba, other China ADRs surge as Ant Group capital plan approval fuels hope for relaxing scrutiny

Alibaba, other China ADRs surge as Ant Group capital plan approval fuels hope for relaxing scrutiny

Ant Group, which previously had its own IPO plans scuttled by regulatory concerns, was allowed to double its registered capital as part of the new plan.